Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJARR CrossMark Policy
    • Publication Ethics
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN (USA): WJARAI || Impact Factor: 8.2 || ISSN Approved Journal

Diffuse Alveolar Hemorrhage as the Initial Presentation of Hepatic Adenocarcinoma: A Case Report

Breadcrumb

  • Home

L. Romane *, K. Mouatassim, M. Ijim, O. Fikri and L. Amro

Department of pulmonology, Hospital ARRAZI, CHU Mohammed VI, Laboratories LRMS, FMPM, UCA.

Case Report

World Journal of Advanced Research and Reviews, 2025, 28(03), 2031-2034

Article DOI: 10.30574/wjarr.2025.28.3.4290

DOI url: https://doi.org/10.30574/wjarr.2025.28.3.4290

Received on 19 November 2025; revised on 26 December 2025; accepted on 29 December 2025

Diffuse alveolar hemorrhage (DAH) is a life-threatening condition resulting from bleeding into the alveolar spaces. It is typically associated with autoimmune vasculitis, infections, drugs, or cardiac disease. Malignancy-related DAH is rare, and cases linked to hepatic adenocarcinoma are extremely uncommon.

We report the case of a 66-year-old male with progressive respiratory failure, severe hypoxemia, and bilateral diffuse alveolo-interstitial infiltrates. Infectious, autoimmune, and cardiac investigations were non-contributory. Chest CT angiography revealed massive DAH. Incidentally, multiple hepatic nodules were identified, and ultrasound-guided biopsy confirmed hepatic adenocarcinoma. The DAH represented an unusual paraneoplastic or metastatic pulmonary manifestation of the tumor.

Although liver cancer frequently metastasizes to the lungs, DAH as its first clinical manifestation is exceptional. Potential mechanisms include fragile tumor-induced neovascularization, pulmonary tumor emboli causing vascular injury, or paraneoplastic immune-mediated capillaritis. Only isolated cases are reported.

In elderly patients with unexplained DAH, especially when constitutional symptoms or extrapulmonary lesions are present, underlying malignancy including hepatic adenocarcinoma should be considered. Early histological sampling is crucial for diagnosis and management.

Diffuse alveolar hemorrhage; Hepatic adenocarcinoma; Liver cancer; Case report

https://journalwjarr.com/sites/default/files/fulltext_pdf/WJARR-2025-4290.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

L. Romane, K. Mouatassim, M. Ijim, O. Fikri and L. Amro. Diffuse Alveolar Hemorrhage as the Initial Presentation of Hepatic Adenocarcinoma: A Case Report. World Journal of Advanced Research and Reviews, 2025, 28(03), 2031-2034. Article DOI: https://doi.org/10.30574/wjarr.2025.28.3.4290.

Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0

Footer menu

  • Contact

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution